[Zhaoyan New Drug: Net profit in the first three quarters increased by 1051.94% year-on-year. Q3 net profit fell 64% month-on-month] On October 28, Zhaoyan New Drug (603127.SH) announced that its operating income in the third quarter was 484 million yuan, a year-on-year increase of 53.01%; the net profit attributable to shareholders of listed companies was 182 million yuan, a year-on-year increase of 821.27%. Operating income in the first three quarters was 1.188 billion yuan, a year-on-year increase of 20.60%; net profit attributable to shareholders of listed companies was 930 million yuan, a year-on-year increase of 1051.94%. The change in performance was mainly due to the recovery in industry demand, the gradual improvement in revenue, and the dual impact of increased gross profit and gains from changes in the fair value of biological assets. Xiaocai Note: The company’s Q3 net profit was 182 million and Q2 net profit was 509 million. Based on this calculation, Q3 net profit dropped 64% from the previous quarter.